Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Primary plasma cell leukemia
Cancer, 11/04/09
Ramsingh G et al. – Primary plasma cell leukemia (PCL) is a rare plasma cell disorder, and current knowledge regarding survival in this disease is limited to small series of patients. Although there has been significant improvement in the survival of patients with multiple myeloma (MM) over the past few decades, it is not known whether there has been a similar trend for PCL.
Related Articles
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia
European Journal of Haematology, 10/14/09
Relevance Score: 81%
Expression of the Brain Transcription Factor OTX1 Occurs in a Subset of Normal Germinal-Center B Cells and in Aggressive Non-Hodgkin Lymphoma
American Journal of Pathology, 11/09/09
Relevance Score: 80%
Management of hematological malignancies during pregnancy
American Journal of Hematology, 10/27/09
Relevance Score: 80%
Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias
Cancer Chemotherapy and Pharmacology, 10/05/09
Relevance Score: 80%
Follicular lymphomas with plasmacytic differentiation include two subtypes
Modern Pathology, 10/22/09
Relevance Score: 78%
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy
Blood, 11/24/09
In vivo biotinylation of the vasculature in B cell lymphoma identifies BST-2 as a target for antibody-based therapy
Blood, 11/24/09
Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1 and CBFB-MYH11 acute myeloid leukemias
Blood, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


